Cansortium Inc. Appoints Ontario Pharmacist Roger Daher to Board of Directors

04/13/2020

MIAMI, April 13, 2020 /PRNewswire/ - Cansortium Inc. ("Cansortium" or the "Company") (CSE: TIUM.U), (OTCQB: CNTMF) a vertically-integrated provider of premium-quality medical cannabis operating under the Fluent™ brand, today announced the appointment of Ontario pharmacist Roger Daher to its Board of Directors.

Mr. Daher has been a licensed pharmacist in Canada for more than 29 years. He is currently a practicing owner/partner in seven Ontario Pharmasave® pharmacies, one of Canada's leading independent pharmacy and drugstore franchise systems. Since 2010, Mr. Daher, has been a member of the Pharmasave Ontario Board of Directors, where he currently serves as treasurer/secretary and as chair of the audit committee. Mr. Daher also serves as a Director of SkyScape Capital Inc. (TSXV: SKY.P) where he is Chief Executive Officer and Board Chairman. Mr. Daher obtained his Bachelor of Science in Pharmacy from the University of Toronto in 1989. 

Neal Hochberg, Executive Chairman of the Board, commented, "We are pleased to welcome Roger to the Cansortium board. His extensive experience in patient care and pharmacy operations will be extremely valuable as the Company continues to expand its Fluent dispensary network to serve the growing number of medical marijuana patients throughout Florida."

Mr. Daher added, "As a career pharmacist, I have seen first-hand the important role that medical cannabis can play in a comprehensive care program for individuals who suffer from acute or chronic physical, psychological or emotional challenges. I am looking forward to serving on the Board of Cansortium to help inform and guide the Company's strategy to further establish the Fluent brand as a leader in providing premium-quality medical cannabis to patients in the largest medical marijuana market in the United States."

About Cansortium Inc.

Headquartered in Miami, Florida, and operating under the Fluent™ brand, Cansortium is focused on being the highest quality cannabis company in the State of Florida driven by unrelenting commitment to operational excellence from seed to sale. Cansortium has developed strong proficiencies in each of cultivation, processing, retail, and distribution activities, the result of successfully operating in the highly regulated cannabis industry. In addition to Florida, Cansortium is seeking to create significant shareholder value in the attractive markets of Texas, Michigan and Pennsylvania, where the Company has secured licenses and established operations.

Cansortium Inc.'s common shares and warrants trade on the CSE under the symbol "TIUM.U" and "TIUM.WT.U", respectively, and on the OTCQB Venture Market under the symbol (OTCQB: CNTMF). Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.

Forward-Looking Information

Certain information in this news release, may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events.

Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

For further information:
www.getfluent.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cansortium-inc-appoints-ontario-pharmacist-roger-daher-to-board-of-directors-301039144.html

SOURCE Cansortium Inc

Cansortium Investors and Media: Neal Hochberg, Executive Chairman, [email protected]; 646-752-5736, [email protected]